These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26919106)

  • 21. Role of NK cells in influenza infection.
    Schultz-Cherry S
    Curr Top Microbiol Immunol; 2015; 386():109-20. PubMed ID: 24992894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early responses of natural killer cells in pigs experimentally infected with 2009 pandemic H1N1 influenza A virus.
    Forberg H; Hauge AG; Valheim M; Garcon F; Nunez A; Gerner W; Mair KH; Graham SP; Brookes SM; Storset AK
    PLoS One; 2014; 9(6):e100619. PubMed ID: 24955764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins.
    Vanderven HA; Ana-Sosa-Batiz F; Jegaskanda S; Rockman S; Laurie K; Barr I; Chen W; Wines B; Hogarth PM; Lambe T; Gilbert SC; Parsons MS; Kent SJ
    EBioMedicine; 2016 Jun; 8():277-290. PubMed ID: 27428437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in receptor binding properties of recent human influenza H3N2 viruses are associated with reduced natural killer cell lysis of infected cells.
    Owen RE; Yamada E; Thompson CI; Phillipson LJ; Thompson C; Taylor E; Zambon M; Osborn HM; Barclay WS; Borrow P
    J Virol; 2007 Oct; 81(20):11170-8. PubMed ID: 17670834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2B4 dysfunction in XLP1 NK cells: More than inability to control EBV infection.
    Pende D; Meazza R; Marcenaro S; Aricò M; Bottino C
    Clin Immunol; 2019 Jul; 204():31-36. PubMed ID: 30391652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease.
    Bottino C; Falco M; Parolini S; Marcenaro E; Augugliaro R; Sivori S; Landi E; Biassoni R; Notarangelo LD; Moretta L; Moretta A
    J Exp Med; 2001 Aug; 194(3):235-46. PubMed ID: 11489943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD48 stimulation by 2B4 (CD244)-expressing targets activates human NK cells.
    Messmer B; Eissmann P; Stark S; Watzl C
    J Immunol; 2006 Apr; 176(8):4646-50. PubMed ID: 16585556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection.
    Draghi M; Pashine A; Sanjanwala B; Gendzekhadze K; Cantoni C; Cosman D; Moretta A; Valiante NM; Parham P
    J Immunol; 2007 Mar; 178(5):2688-98. PubMed ID: 17312110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus.
    He W; Tan GS; Mullarkey CE; Lee AJ; Lam MM; Krammer F; Henry C; Wilson PC; Ashkar AA; Palese P; Miller MS
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11931-11936. PubMed ID: 27698132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impairment in cytotoxicity and expression of NK cell- activating receptors on human NK cells following exposure to asbestos fibers.
    Nishimura Y; Miura Y; Maeda M; Kumagai N; Murakami S; Hayashi H; Fukuoka K; Nakano T; Otsuki T
    Int J Immunopathol Pharmacol; 2009; 22(3):579-90. PubMed ID: 19822075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses.
    Jegaskanda S; Vandenberg K; Laurie KL; Loh L; Kramski M; Winnall WR; Kedzierska K; Rockman S; Kent SJ
    J Infect Dis; 2014 Dec; 210(11):1811-22. PubMed ID: 24916185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.
    Tangye SG; Phillips JH; Lanier LL; Nichols KE
    J Immunol; 2000 Sep; 165(6):2932-6. PubMed ID: 10975798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NK cell regulation by SLAM family receptors and SAP-related adapters.
    Veillette A
    Immunol Rev; 2006 Dec; 214():22-34. PubMed ID: 17100873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic redistribution of the activating 2B4/SAP complex at the cytotoxic NK cell immune synapse.
    Roda-Navarro P; Mittelbrunn M; Ortega M; Howie D; Terhorst C; Sánchez-Madrid F; Fernández-Ruiz E
    J Immunol; 2004 Sep; 173(6):3640-6. PubMed ID: 15356108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of MHC class I proteins with the 2B4 receptor inhibits self-killing of human NK cells.
    Betser-Cohen G; Mizrahi S; Elboim M; Alsheich-Bartok O; Mandelboim O
    J Immunol; 2010 Mar; 184(6):2761-8. PubMed ID: 20164429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2B4 (CD244)-mediated activation of cytotoxicity and IFN-gamma release in human NK cells involves distinct pathways.
    Chuang SS; Kumaresan PR; Mathew PA
    J Immunol; 2001 Dec; 167(11):6210-6. PubMed ID: 11714782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu.
    Shah AH; Sowrirajan B; Davis ZB; Ward JP; Campbell EM; Planelles V; Barker E
    Cell Host Microbe; 2010 Nov; 8(5):397-409. PubMed ID: 21075351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activating interactions in human NK cell recognition: the role of 2B4-CD48.
    Nakajima H; Cella M; Langen H; Friedlein A; Colonna M
    Eur J Immunol; 1999 May; 29(5):1676-83. PubMed ID: 10359122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2B4 expression on natural killer cells increases in HIV-1 infected patients followed prospectively during highly active antiretroviral therapy.
    Ostrowski SR; Ullum H; Pedersen BK; Gerstoft J; Katzenstein TL
    Clin Exp Immunol; 2005 Sep; 141(3):526-33. PubMed ID: 16045743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
    Banerjee P; Feuer G; Barker E
    J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.